How AI Helps Advance Immunotherapy And Precision Medicine

While immunotherapies have revolutionized cancer treatment, they are currently effective only for a small subset (from 20% to 30%) of patients. Tel-Aviv-based Nucleai is developing AI software for image analysis and modeling of pathology data to assist in the development of more effective drugs. The long-term goal of the 3-year-old startup is to be “a […]

Add Your Heading Text Here